Litcius/Paper detail

The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Yohann Loriot, Matthieu Texier, Stéphane Culine, Aude Fléchon, Antoine Thiery-Vuillemin, Gwénaëlle Gravis, L. Geoffrois, Christine Chevreau, Marine Gross‐Goupil, Philippe Barthélémy, Emmanuelle Bompas, Hakim Mahammedi, Brigitte Laguerre, Sophie Abadie Lacourtoisie, Carole Hélissey, Sylvain Ladoire, Christine Abraham, Christophe Massard, Séréna Grimaldi, Karim Fizazi

2022European Urology43 citationsDOI

Topics & Concepts

MedicineSeminomaCarboplatinPositron emission tomographyNuclear medicineFluorodeoxyglucoseChemotherapyRadiologyInternal medicineCisplatinTesticular diseases and treatmentsGlioma Diagnosis and TreatmentSarcoma Diagnosis and Treatment
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography | Litcius